Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Active & Responsive
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
for
Hereditary Hemorrhagic Telangiectasia (HHT),
Location: Dallas TX, St Louis MO, Indianapolis IN, Rochester MN,
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Location: Dallas TX, Austin TX, Houston TX, St Louis MO,
Sponsor: Abbott Medical Devices
Sex: All
Age: 22 - 70
Code: NCT06423430
Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for
Gastric Adenocarcinoma,
Location: Dallas TX, Westwood KS, Chicago IL, Milwaukee WI,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05365581
Phase 1, Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Dallas TX, St Louis MO, Birmingham AL, Aurora CO,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Dallas TX, Houston TX, Little Rock AR, New Orleans LA,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase 3, Recruiting
Active & Responsive
VEL-101 to Prevent Rejection After Kidney Transplantation
for
Transplantation, Kidney
Location: Dallas TX
Sponsor: Veloxis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07290777
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: Dallas TX, Atlanta GA, Philadelphia PA, New York NY,
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07517133
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
for
Transfusion-dependent Alpha-Thalassemia,
Location: Dallas TX, Atlanta GA, Philadelphia PA, New York NY
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07506863
Phase 3, Recruiting
Active & Responsive
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
for
Cystic Fibrosis (CF), New Diagnostics
Location: Dallas TX, St Louis MO, Minneapolis MN, Milwaukee WI,